A chemically defined medium containing nicotinamide adenine dinucleotide (NAD) supported the growth of ActinobaciZZus pleuropneumoniae biotype 2 (Bertschinger 2008/76), whereas the same medium lacking NAD did not. Nicotinamide mononucleotide, nicotinamide riboside, and nicotinamide could substitute for NAD, whereas nicotinic acid adenine dinucleotide, nicotinic acid mononucleotide, nicotinic acid, and quinolinic acid could not. Hence, although described as being V factor independent, this organism can exhibit V-factor-dependent growth.
The organism known previously as Haemophilirs pleuropneumoniae (3) and now referred to as Actinobacillus pleuropneumoniae biotype 1 (7) requires V factor for growth; whereas nicotinamide adenine dinucleotide (N AD), nicotinamide mononucleotide (NMN), and nicotinamide riboside (NR) can serve as V factor, nicotinamide (NAm) and the acid analogs of these compounds cannot (4) . A. pleuropneirmoniae biotype 2, on the other hand, is described as being V factor independent (7). However, to our knowledge, it remains unknown whether A . pleuropneumoniae biotype 2 can synthesize NAD de novo, unlike biotype 1 (3, or requires for growth some form of pyridine nucleotide precursor, such as NAm. In this respect, note that most complex media probably contain NAm or nicotinic acid or both. Therefore, the purpose of the present study was to grow A . pleuropneumoniae biotype 2 in a chemically defined medium (CDM) and to determine the requirement, if any, for an exogenous pyridine nucleotide precursor.
Cultures of A. pleuropneumoniae biotype 2 (Bertschinger 2008/76) were stored and frozen inocula were prepared as described previously (6). To obtain organisms for inoculation of CDM, frozen inocula (6) were thawed rapidly, and 0.05-ml volumes were used to inoculate 20-ml volumes of tryptone-yeast extract medium (6) contained in 125-ml flasks fitted with Kaput closures (Bellco Glass, Inc., Vineland, N.J.). These cultures were incubated for 8 h at 37°C with agitation on a gyratory shaker (200 rpm). The organisms from these early stationary phase cultures (optical density at 660 nm [OD66,], -2.2; model 240 spectrophotometer; Gilford Instrument Laboratories, Inc., Oberlin, Ohio) were harvested by centrifugation (21,000 x g , 20 min), washed with an equal volume of sterile saline, and resuspended similarly. Portions (0.2 ml) of such suspensions were added to 125-ml flasks (as described above) containing 20-ml volumes of CDM; this medium was prepared as described by Herriott et al. (2) , except that sodium lactate, hemin, nitrilotriethanol, and NAD were omitted, and glucose and FeCI, were incorporated to give final concentrations of 10 mM and 10 pM, respectively. Such cultures in CDM were incubated as described above, but for 15 h. By this time growth had ceased (OD6607 -0.35), presumably due to pyridine nucleotide source limitation as growth resumed if cultures were supplemented with 0.5 pM NAD; a similar phenomenon has been observed with A . pleuropneumoniae biotype 1 (4). The organisms from these CDM cultures were harvested, * Corresponding author.
washed, and resuspended as described above, and 0.2-ml volumes were used to inoculate triplicate 20-ml volumes of CDM that did or did not contain the filter-sterilized pyridine nucleotide or precursor (0.5 pM) under study. NR was produced and NR, NMN, and NAD were purified and analyzed as described previously ( 3 , except that a step gradient of HCOOH (increments of 0.1 M) was used to elute a column (1.5 by 5.5 cm) of anion exchange resin (Dowexformate). Quinolinic acid, nicotinic acid, nicotinic acid mononucleotide, nicotinic acid adenine dinucleotide, and NAm were used without further purification. The latter cultures were incubated at 37°C with agitation (200 rpm), and growth was monitored turbidimetrically at 660 nm by using 0.45-ml samples. Figure 1 depicts the growth of A . pleuropneumoniae biotype 2 (Bertschinger 2008/76) in CDM supplemented with NAD, NMN, NR, or NAm. Mean generation times of 86 min (CDM containing NAD), 94 min (CDM containing NMN), 98 rnin (CDM containing NR), and 83 rnin (CDM containing NAm) were calculated from the linear portions of the plots; consideration of the first three (CDM containing NAm), four (CDM containing NR or NMN), or five (CDM containing NAD) data points (i.e., OD660 of <0.55) gave correlation coefficients of greater than 0.999. On the other hand, no growth was observed when the organisms were incubated in nonsupplemented CDM or in CDM supplemented with quinolinic acid, nicotinic acid, nicotinic acid mononucleotide, or nicotinic acid adenine dinucleotide; the OD,,, values of these cultures remained constant at approximately 0.003 for at least 36 h. These data demonstrate that the growth of A . pleuropneumoniae biotype 2 (Bertschinger 2008/76) requires the presence of specific pyridine nucleotides or pyridine nucleotide precursors. Although further studies will be required to confirm such a suggestion, the data also indicate that A . pleuropneumoniae biotype 2 (Bertschinger 2008/76), like biotype 1 (3, cannot synthesize NAD de novo.
The most interesting outcome of these experiments is that they present us with a significant dilemma; namely, they demonstrate that A . pleuropneumoniae biotype 2 (Bertschinger 2008/76), although described as being V factor independent, can exhibit V-factor (NAD, NMN, or NR)-dependent growth. On the other hand, NAm, which cannot support the growth of A . pleuropneumoniae biotype 1 (4), can satisfy the requirement of the biotype 2 organism for a pyridine nucleotide precursor. However, as none of several other compounds involved in procaryotic pyridine nucleo- ition to the dilemma is the inclusion of NAm among the compounds that can serve as V factor. A V-factor-dependent organism could then be defined as an organism that requires a pyridine nucleotide source for growth and can use at least one, but not necessarily all, of the newly defined V-factor compounds (nicotinamide adenine dinucleotide phosphate, NAD, NMN, NR, NAm) for this purpose. When this defiinition is used, and provided that other A . pleuropneumoniue lbiotype 2 strains exhibit a requirement for either NAD, NMN, NR, or NAm, all A . pleuropneumoniae strains could Ibe described as being V factor dependent, with biotype 1 and lbiotype 2 reflecting the capacity to utilize NAm. In our opinion, the only alternative is that V-factor terminology be abandoned.
